We then evaluated the antiproliferative potential of the compounds by carrying out viability assays in HT-29, a CRC-derived cell line selected as it expresses substantial amounts of PPARγ1 with respect to the α and β/δ subtypes. This evidence concerns the gene PPARG and colorectal carcinoma.